> top > docs > PubMed:32603531 > annotations

PubMed:32603531 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 255-260 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576
T2 676-683 Body_part denotes Protein http://purl.org/sig/ont/fma/fma67257
T3 691-702 Body_part denotes lymphocytes http://purl.org/sig/ont/fma/fma62863
T4 1071-1075 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T5 1101-1106 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576
T6 1390-1394 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T7 1686-1690 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 255-260 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443
T2 1071-1075 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T3 1101-1106 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443
T4 1390-1394 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T5 1686-1690 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 49-57 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T2 314-322 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 323-332 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T4 449-457 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 458-467 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T6 1543-1551 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T7 1552-1561 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T8 1787-1795 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T9 1796-1805 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 59-60 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T2 93-96 http://purl.obolibrary.org/obo/PR_000001343 denotes aim
T3 245-250 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T4 255-260 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T5 356-357 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T6 924-925 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T7 1034-1036 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T8 1071-1075 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T9 1071-1075 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T10 1101-1106 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T11 1390-1394 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T12 1390-1394 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T13 1676-1681 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T14 1686-1690 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T15 1686-1690 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T16 1845-1846 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 151-161 Chemical denotes febuxostat http://purl.obolibrary.org/obo/CHEBI_31596
T2 187-205 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T3 676-683 Chemical denotes Protein http://purl.obolibrary.org/obo/CHEBI_16541

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 649-658 http://purl.obolibrary.org/obo/GO_0007585 denotes breathing

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-58 Sentence denotes Febuxostat therapy in outpatients with suspected COVID-19:
T2 59-76 Sentence denotes A clinical trial.
T3 77-88 Sentence denotes BACKGROUND:
T4 89-333 Sentence denotes The aim of this clinical trial was to evaluate the effects of febuxostat (FBX) in comparison with hydroxychloroquine (HCQ) on clinical symptoms, laboratory tests and chest CT findings in outpatients with moderate symptoms of COVID-19 infection.
T5 334-342 Sentence denotes METHODS:
T6 343-468 Sentence denotes We conducted a clinical trial involving adult outpatients with the moderate respiratory illness following COVID-19 infection.
T7 469-541 Sentence denotes Patients were randomly assigned to receive either FBX or HCQ for 5 days.
T8 542-771 Sentence denotes The measured variables were needs to hospitalisation, clinical and laboratory data including fever, cough, breathing rate, C-Reactive Protein level, lymphocytes count at onset of admission and was well as at 5 days of treatments.
T9 772-867 Sentence denotes In addition, CT findings were evaluated on admission and 14 days after initiation of treatment.
T10 868-876 Sentence denotes RESULTS:
T11 877-961 Sentence denotes Sixty subjects were enrolled in the study with a 1 to 1 ratio in FBX and HCQ groups.
T12 962-1211 Sentence denotes On admission, fever (66.7%), cough (87%), tachypnoea (44.4%), dyspnoea (35%), elevated CRP value (94.4%) and lung involvement according to chest CT (100%) were documented in enrolled patients with insignificant difference between FBX and HCQ groups.
T13 1212-1365 Sentence denotes Fever, cough and tachypnoea were significantly mitigated in both groups after five days of treatments without any significant differences between groups.
T14 1366-1507 Sentence denotes The mean percentages of lung involvement were significantly reduced to 7.3% and 8% after 14 days of treatment with FBX and HCQ, respectively.
T15 1508-1703 Sentence denotes In adult outpatients with moderate COVID-19 infection, the effectiveness of FBX and HCQ was not different in terms of resolution of clinical manifestations, laboratory tests and lung CT findings.
T16 1704-1715 Sentence denotes CONCLUSION:
T17 1716-1885 Sentence denotes This trial suggests that FBX is as an alternative treatment to HCQ for COVID-19 infection and may be considered in patients with a contraindication or precaution to HCQ.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 419-438 Phenotype denotes respiratory illness http://purl.obolibrary.org/obo/HP_0002086
T2 635-640 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T3 642-647 Phenotype denotes cough http://purl.obolibrary.org/obo/HP_0012735
T4 976-981 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T5 991-996 Phenotype denotes cough http://purl.obolibrary.org/obo/HP_0012735
T6 1024-1032 Phenotype denotes dyspnoea http://purl.obolibrary.org/obo/HP_0002094
T7 1040-1052 Phenotype denotes elevated CRP http://purl.obolibrary.org/obo/HP_0011227
T8 1212-1217 Phenotype denotes Fever http://purl.obolibrary.org/obo/HP_0001945
T9 1219-1224 Phenotype denotes cough http://purl.obolibrary.org/obo/HP_0012735

hydroxychloroquine

Id Subject Object Predicate Lexical cue hp_id
T1 419-438 Phenotype denotes respiratory illness http://purl.obolibrary.org/obo/HP_0002086
T2 635-640 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T3 642-647 Phenotype denotes cough http://purl.obolibrary.org/obo/HP_0012735
T4 976-981 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T5 991-996 Phenotype denotes cough http://purl.obolibrary.org/obo/HP_0012735
T6 1024-1032 Phenotype denotes dyspnoea http://purl.obolibrary.org/obo/HP_0002094
T7 1040-1052 Phenotype denotes elevated CRP http://purl.obolibrary.org/obo/HP_0011227
T8 1212-1217 Phenotype denotes Fever http://purl.obolibrary.org/obo/HP_0001945
T9 1219-1224 Phenotype denotes cough http://purl.obolibrary.org/obo/HP_0012735